全文获取类型
收费全文 | 78247篇 |
免费 | 6755篇 |
国内免费 | 3030篇 |
专业分类
耳鼻咽喉 | 790篇 |
儿科学 | 1874篇 |
妇产科学 | 1541篇 |
基础医学 | 7936篇 |
口腔科学 | 1322篇 |
临床医学 | 7535篇 |
内科学 | 8329篇 |
皮肤病学 | 933篇 |
神经病学 | 2966篇 |
特种医学 | 3715篇 |
外国民族医学 | 54篇 |
外科学 | 9229篇 |
综合类 | 13504篇 |
现状与发展 | 22篇 |
预防医学 | 3340篇 |
眼科学 | 661篇 |
药学 | 6088篇 |
53篇 | |
中国医学 | 2574篇 |
肿瘤学 | 15566篇 |
出版年
2024年 | 203篇 |
2023年 | 1154篇 |
2022年 | 2504篇 |
2021年 | 3293篇 |
2020年 | 2747篇 |
2019年 | 2368篇 |
2018年 | 2237篇 |
2017年 | 2549篇 |
2016年 | 2880篇 |
2015年 | 3084篇 |
2014年 | 5028篇 |
2013年 | 4996篇 |
2012年 | 4404篇 |
2011年 | 4952篇 |
2010年 | 4003篇 |
2009年 | 3929篇 |
2008年 | 3936篇 |
2007年 | 4173篇 |
2006年 | 3735篇 |
2005年 | 3276篇 |
2004年 | 2850篇 |
2003年 | 2416篇 |
2002年 | 2176篇 |
2001年 | 1954篇 |
2000年 | 1626篇 |
1999年 | 1465篇 |
1998年 | 1261篇 |
1997年 | 1152篇 |
1996年 | 1011篇 |
1995年 | 929篇 |
1994年 | 788篇 |
1993年 | 628篇 |
1992年 | 529篇 |
1991年 | 441篇 |
1990年 | 372篇 |
1989年 | 349篇 |
1988年 | 350篇 |
1987年 | 293篇 |
1986年 | 234篇 |
1985年 | 291篇 |
1984年 | 279篇 |
1983年 | 176篇 |
1982年 | 213篇 |
1981年 | 182篇 |
1980年 | 125篇 |
1979年 | 122篇 |
1978年 | 101篇 |
1977年 | 66篇 |
1976年 | 62篇 |
1975年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
目的 :探讨联合菌苗防治肿瘤的作用。方法采用动物体内实验 ,动物为封闭群KM小鼠 ,菌株为 2 6 0 0 3- 2 1、4 482 4 - 3及 932 0 1- 3,瘤种为S180 。所有实验小鼠接种S180 后 ,按随机对照试验设计分成 5组 ,即三个不同的单价菌苗组、一个联合菌苗组及一个对照组 ,同期观察联合菌苗对S180 增长的影响。结果 :三个不同的单价菌苗组及联合菌苗组的平均瘤重均比对照组低 ,联合菌苗组的平均瘤重比单价菌苗组的更低 ,差异均有高度统计学意义 (P <0 .0 1~ 0 .0 0 1) ;三个不同单价菌苗组的抑瘤率分别为 5 0 .6 %、4 8.3%、4 5 .5 % ,联合菌苗组抑瘤率为 75 .0 %。结论 :实验所选用的菌苗能抑制S180 的增长 ,联合菌苗的效果更好 相似文献
92.
分析原发性腹膜后恶性肿瘤12例。83%以腹块和腹痛为主要症状,体征中腹块占91.5%,以恶性淋巴瘤居首位占61%。全组完全切除率为58%,行脏器联合切除占25%。完全切除加放疗、化疗3年存活率为28.5%,部分切除及活检未给其它治疗者5例预后差,均1年内死亡,差别显著。 相似文献
93.
Prevention of Bone Loss by Clodronate in Early Postmenopausal Women with Vertebral Osteopenia: A Dose-Finding Study 总被引:1,自引:0,他引:1
M. J. V?lim?ki K. Laitinen K. Laitinen A. Patronen H. Puolijoki H. Puolijoki J. Sepp?nen L. Pylkk?nenand the Probone Study Group 《Osteoporosis international》2002,13(12):937-947
This double-masked, placebo-controlled study was undertaken to determine the efficacy and safety of oral clodronate in the
prevention of bone loss in early postmenopausal women with vertebral osteopenia. Altogether 610 women with a mean age of 53
years were recruited for the study. They were 1–5 years postmenopausal and their lumbar spine bone mineral density (BMD) was
at least 1 standard deviation below the mean of premenopausal women (T-score ≤−1). The subjects were randomized into five study groups to receive either placebo, clodronate 65 mg, 400 mg or 800
mg daily, or intermittent clodronate in 3 month cycles with 400 mg daily for 15 days followed with no treatment for 75 days
for 3 years. One hundred and eighty-seven of 509 women who completed the primary study continued in the extension study of
2 years in which previous placebo users were switched to clodronate 800 mg daily, while previous users of 400 mg or 800 mg
of clodronate used either placebo or 800 mg of clodronate daily. In the primary study clodronate was administered in the evening,
and in the extension 1 h before breakfast on an empty stomach. In the primary study mean changes in lumbar spine BMD were
−3.4% in the placebo group and +0.4% in 800 mg clodronate group [difference between groups at 3 years 3.8% (95% CI 2.7% to
4.9%, p<0.0001)], and in the trochanter area BMD −1.1% in the placebo group, and + 0.4% in the 800 mg clodronate group [difference
between groups at 3 years 1.5% (95% CI 0.05% to 2.9%)]. During the extension study mean changes in lumbar spine BMD were +1.5%
in the clodronate group and −0.2 % in the placebo group [difference between groups 1.7% (CI 0.4% to 3.0%, p = 0.010)] and in trochanter BMD were +2.5% in the clodronate group and no change in the placebo group [difference between
groups 2.1% (CI 0.3% to 3.9%, p = 0.007)]. No statistically significant differences between the placebo and 800 mg clodronate groups were found in the femoral
neck BMD. In the primary study the urinary excretion of type I collagen aminoterminal telopeptide (NTX) decreased by 44% (p<0.0001 compared with placebo) and that of deoxypyridinoline by 18% (p<0.0001) in the clodronate 800 mg group. In the extension study urinary NTX decreased by 51% (p<0.0001) in those who were switched to 800 mg of clodronate and increased by 67% (p<0.0001) in those who stopped using that dose. There was no difference in the frequency of gastrointestinal complaints between
clodronate- and placebo-treated patients in the primary study, but they were more common among women who received clodronate
in the extension phase. Clodronate in daily doses of 400–800 mg caused a slight elevation of aminotransferase levels, usually
within the reference range. In bone biopsies no defect in mineralization was found. In conclusion, clodronate in a daily dose
of 800 mg prevents early postmenopausal bone loss at the sites of the skeleton in which cancellous bone predominates. It effectively
reduces bone resorption and bone turnover rate. Antifracture efficacy of clodronate remains to be established by prospective,
placebo-controlled trials.
Received: 4 March 2002 / Accepted: 9 July 2002 相似文献
94.
卵巢恶性肿瘤与血小板增多关系分析 总被引:1,自引:0,他引:1
李洁华 《中国现代医药杂志》2005,7(5):48-49
目的探讨卵巢恶性肿瘤伴发血小板增多的临床规律。方法回顾分析98例卵巢恶性肿瘤患者的临床资料,26例合并血小板增多。结果血小板增多占26.5%,其中晚期(Ⅲ+Ⅳ期)占88.46%,晚期患者血小板偏高明显增多,且肿瘤切除后血小板下降。结论卵巢恶性肿瘤伴发血小板增多晚期患者多见,预后差,血小板增多可作为判断卵巢肿瘤恶性程度及术后随访的指标。 相似文献
95.
Paul Steinbok Ken Poskitt D. Douglas Cochrane O. Olof Flodmark 《Child's nervous system》1991,7(1):16-20
Enhanced and non-enhanced computed tomography (CT) brain scans were performed within 72 h of surgery on 21 children in whom brain tumors had been resected totally or subtotally, and scans were repeated at varying intervals thereafter. Biopsies of the resection margins were performed in 12 patients at the end of the surgical procedure. The immediate CT scan showed enhancement in the resection margin in 13 of the 21 patients and in 9 of the 13, the enhancement disappeared on follow-up scans. There was discordance between the results of immediate CT scan examination and the biopsies of the resection margins in 7 of the 12 cases. The advantages and disadvantages of an immediate postoperative scan versus a more delayed CT scan are discussed. 相似文献
96.
A case of papilliferous keratoameloblastoma is reported which is only the second ever documented. The patient was a 76-yr-old black woman with a large expansile multilocular radiolucency of the body, angle and ramus of the mandible. Histologically the lesion consisted of sheets of cystic follicles filled with necrotic debris and sometimes parakeratin. The vast majority of the follicles were lined by a papilliferous epithelium consisting of large rounded cells with centrally placed nuclei. True papillary projections with cores of connective tissue were also present. The remainder of the follicles were lined by a thin parakeratinising stratified squamous epithelium. Histological features characteristic of ameloblastoma were absent. Final classification of these lesions will have to await the reporting of further cases. 相似文献
97.
98.
急性脑血管病肿瘤坏死因子-α的临床研究 总被引:1,自引:0,他引:1
目的:探讨肿瘤坏死因子-α(TNF-α)在急性脑血管病(ACVD)中的作用及其变化的临床意义。方法:选取95例ACVD患者,并设性别及年龄相匹配的血清对照组(20例)及脑脊液对照组(10例)。应用酶联免疫吸附法(ELISA)于发病后第1、3、7、14d测定血清和脑脊液中TNF-α。结果:①三种脑血管病患者血清TNF-α动态变化存在差异,脑出血和脑梗死组的峰值单间为发病后第3d,而蛛网膜下腔出血(SAH)组为第1d。②脑梗死患者血清TNF-α水平与梗死面积、神经功能缺损程度及病情恶化与否相关。③SAH组于发病后第1d、3d、7d脑脊液TNF-α值高于血清,14d时降至对照组水平并与血清无差异。结论:①脑梗死患者血清TNF-α的动态观察,可为临床预测梗死灶大小、神经功能缺损程度及病情恶化与否提供依据。②发病早期的脑梗死患者若CT未能显示病灶时,血清TNF-α的明显升高有助于临床诊断和治疗。③SAH患者脑脊液中TNF-α水平明显高于血清,进一步提示脑内神经组织可产生TNF-α。脑脊液中TNF-α的持续明显升高可能与SAH后脑血管痉挛有关。④TNF-α参与了ACVD的炎性反应过程,早期抑制TNF产生及抗炎性反应的治疗可能具有潜在的临床价值。 相似文献
99.
复方华蟾胶囊抗小鼠肿中瘤作用的实验研究 总被引:2,自引:0,他引:2
目的了解复方华蟾胶囊抗小鼠移植性肿瘤的作用.方法以小鼠肝癌22(H22)、小鼠肉瘤180(S180)为瘤株,应用动物移植性肿瘤的体内试验法对药物进行抗癌药效学试验.结果复方华蟾胶囊灌胃4,2 g/kg@d,连续14 d,对小鼠移植性肝癌实体型生长有明显的抑制作用,抑瘤率分别为38.09%,30.95%.对小鼠移植性S180实体型生长有明显的抑制作用,抑瘤率分别为34.7%,30.08%.复方华蟾胶囊对荷瘤小鼠的胸腺和脾脏重量无影响.结论复方华蟾胶囊在试验条件下有一定抗肿瘤作用. 相似文献
100.
树突状细胞激活的肿瘤浸润性淋巴细胞体外对自体肝癌细胞杀伤活性的研究 总被引:1,自引:0,他引:1
目的探讨树突状细胞(DC)激活的肿瘤浸润性淋巴细胞(TIL)体外对自体肝癌细胞杀伤活性.方法从肝癌患者外周血获取DC,应用粒/巨噬细胞集落刺激因子(GM-CSF)、白细胞介素-4(IL-4)和肿瘤抗原激活DC,然后用DC来激活TIL,观察TIL在体外对自体肝癌细胞的杀伤活性.结果DC激活的TIL具有很高的对自体肝癌细胞杀伤活性,杀伤率为(89.39±3.05)%,明显高于未经DC激活的TIL、CD激活的T淋巴细胞和未经DC激活的T淋巴细胞对自体肝癌细胞的杀伤率.结论肝癌患者外周血DC能诱导TIL产生高效而特异的抗肝癌免疫. 相似文献